Health8/14/2025•The Guardian
Abortion drug could help reduce risk of breast cancer, group of medics says
According to an international group of doctors and scientists, the abortion drug mifepristone could help reduce the risk of breast cancer in women at high risk. The experts, writing in The Lancet, claim that "stigma" around the drug is preventing pharmaceutical companies from exploring its potential as a new preventive treatment. The article suggests that further research is needed to investigate the possible benefits of using mifepristone to lower the risk of breast cancer in women, but the negative perception surrounding the drug is hindering progress in this area of reproductive health.
Note: This is an AI-generated summary of the original article. For the full story, please visit the source link below.
